Innovation Pharmaceuticals Inc
OTC:IPIX
Income Statement
Earnings Waterfall
Innovation Pharmaceuticals Inc
Income Statement
Innovation Pharmaceuticals Inc
| Jun-2007 | Sep-2007 | Dec-2007 | Mar-2008 | Jun-2008 | Sep-2008 | Dec-2008 | Mar-2009 | Jun-2009 | Sep-2009 | Dec-2009 | Mar-2010 | Jun-2010 | Sep-2010 | Dec-2010 | Mar-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
3
|
5
|
5
|
5
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+6%
|
0
-95%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
(6)
|
(5)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(6)
|
(8)
|
(11)
|
(13)
|
(13)
|
(13)
|
(11)
|
(12)
|
(13)
|
(12)
|
(13)
|
(13)
|
(13)
|
(15)
|
(17)
|
(18)
|
(17)
|
(14)
|
(11)
|
(9)
|
(8)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(7)
|
(8)
|
(9)
|
(10)
|
(8)
|
(8)
|
(7)
|
(6)
|
(5)
|
(4)
|
(3)
|
(2)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(4)
|
(3)
|
(4)
|
(3)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(6)
|
(10)
|
(11)
|
(11)
|
(11)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(13)
|
(14)
|
(15)
|
(14)
|
(11)
|
(9)
|
(6)
|
(5)
|
(4)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
0
|
(3)
|
(7)
|
(5)
|
(6)
|
(6)
|
(4)
|
(4)
|
(2)
|
(1)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(3)
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
+20%
|
(0)
-275%
|
(0)
-113%
|
(1)
-56%
|
(1)
-38%
|
(1)
-29%
|
(1)
-52%
|
(1)
-7%
|
(2)
-24%
|
(3)
-48%
|
(3)
-5%
|
(3)
-20%
|
(4)
-14%
|
(4)
-3%
|
(5)
-37%
|
(6)
-6%
|
(6)
+2%
|
(5)
+4%
|
(4)
+28%
|
(4)
-8%
|
(4)
+12%
|
(3)
+10%
|
(3)
-2%
|
(3)
+13%
|
(3)
-17%
|
(4)
-25%
|
(6)
-34%
|
(8)
-38%
|
(11)
-43%
|
(13)
-10%
|
(13)
-5%
|
(13)
+2%
|
(11)
+14%
|
(12)
-5%
|
(13)
-7%
|
(12)
+4%
|
(13)
-9%
|
(13)
0%
|
(13)
-1%
|
(15)
-15%
|
(17)
-10%
|
(18)
-7%
|
(17)
+8%
|
(14)
+16%
|
(11)
+18%
|
(9)
+22%
|
(8)
+14%
|
(6)
+16%
|
(5)
+16%
|
(5)
+12%
|
(5)
+4%
|
(5)
-2%
|
(5)
-4%
|
(7)
-43%
|
(8)
-14%
|
(9)
-14%
|
(10)
-10%
|
(8)
+14%
|
(8)
+7%
|
(7)
+12%
|
(6)
+12%
|
(5)
+25%
|
(4)
+18%
|
(3)
+22%
|
(2)
+20%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(4)
|
(4)
|
(3)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(3)
|
(5)
|
(5)
|
(5)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
+20%
|
(0)
-275%
|
(0)
-113%
|
(1)
-59%
|
(1)
-39%
|
(1)
-28%
|
(1)
-52%
|
(1)
-8%
|
(2)
-23%
|
(3)
-48%
|
(3)
-6%
|
(3)
-20%
|
(4)
-14%
|
(4)
-4%
|
(6)
-37%
|
(6)
-7%
|
(6)
+1%
|
(7)
-12%
|
(5)
+30%
|
(5)
-6%
|
(4)
+10%
|
(3)
+30%
|
(4)
-18%
|
(3)
+12%
|
(4)
-16%
|
(5)
-23%
|
(6)
-32%
|
(8)
-36%
|
(12)
-41%
|
(13)
-10%
|
(13)
-4%
|
(13)
+2%
|
(11)
+14%
|
(12)
-5%
|
(13)
-7%
|
(13)
-1%
|
(13)
-3%
|
(13)
0%
|
(14)
-1%
|
(16)
-15%
|
(17)
-10%
|
(18)
-7%
|
(17)
+8%
|
(16)
+2%
|
(14)
+15%
|
(13)
+4%
|
(12)
+10%
|
(9)
+28%
|
(8)
+6%
|
(7)
+17%
|
(7)
+2%
|
(7)
+1%
|
(6)
+6%
|
(10)
-57%
|
(13)
-30%
|
(14)
-9%
|
(15)
-6%
|
(10)
+29%
|
(8)
+24%
|
(7)
+12%
|
(6)
+9%
|
(5)
+24%
|
(4)
+16%
|
(3)
+23%
|
(3)
+17%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(6)
|
(6)
|
(6)
|
(7)
|
(5)
|
(5)
|
(4)
|
(3)
|
(4)
|
(3)
|
(4)
|
(5)
|
(6)
|
(8)
|
(12)
|
(13)
|
(13)
|
(13)
|
(11)
|
(12)
|
(13)
|
(13)
|
(13)
|
(13)
|
(14)
|
(16)
|
(17)
|
(18)
|
(17)
|
(16)
|
(14)
|
(13)
|
(12)
|
(9)
|
(8)
|
(7)
|
(7)
|
(7)
|
(6)
|
(10)
|
(13)
|
(14)
|
(15)
|
(10)
|
(8)
|
(7)
|
(6)
|
(5)
|
(4)
|
(3)
|
(3)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
+20%
|
(0)
-275%
|
(0)
-113%
|
(1)
-59%
|
(1)
-39%
|
(1)
-28%
|
(1)
-52%
|
(1)
-8%
|
(2)
-23%
|
(3)
-48%
|
(3)
-6%
|
(3)
-20%
|
(4)
-14%
|
(4)
-4%
|
(6)
-37%
|
(6)
-7%
|
(6)
+1%
|
(7)
-12%
|
(5)
+30%
|
(5)
-8%
|
(5)
+6%
|
(3)
+28%
|
(4)
-17%
|
(3)
+12%
|
(4)
-9%
|
(7)
-76%
|
(8)
-22%
|
(10)
-27%
|
(14)
-33%
|
(13)
+6%
|
(13)
-4%
|
(13)
+2%
|
(11)
+14%
|
(12)
-5%
|
(13)
-7%
|
(13)
-1%
|
(13)
-3%
|
(13)
0%
|
(14)
-1%
|
(16)
-15%
|
(17)
-10%
|
(18)
-7%
|
(17)
+8%
|
(16)
+2%
|
(14)
+15%
|
(13)
+4%
|
(12)
+10%
|
(9)
+28%
|
(8)
+6%
|
(7)
+17%
|
(7)
+2%
|
(7)
+1%
|
(6)
+6%
|
(10)
-57%
|
(13)
-30%
|
(14)
-9%
|
(15)
-6%
|
(10)
+29%
|
(8)
+24%
|
(7)
+12%
|
(6)
+9%
|
(5)
+24%
|
(4)
+16%
|
(3)
+23%
|
(3)
+17%
|
|
| EPS (Diluted) |
0
N/A
|
-0.04
N/A
|
0
N/A
|
0
N/A
|
-0.01
N/A
|
0
N/A
|
0
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.02
N/A
|
-0.03
-50%
|
-0.03
N/A
|
-0.04
-33%
|
-0.04
N/A
|
-0.04
N/A
|
-0.06
-50%
|
-0.07
-17%
|
-0.06
+14%
|
-0.07
-17%
|
-0.04
+43%
|
-0.06
-50%
|
-0.05
+17%
|
-0.04
+20%
|
-0.05
-25%
|
-0.04
+20%
|
-0.04
N/A
|
-0.06
-50%
|
-0.07
-17%
|
-0.1
-43%
|
-0.12
-20%
|
-0.11
+8%
|
-0.11
N/A
|
-0.11
N/A
|
-0.09
+18%
|
-0.1
-11%
|
-0.11
-10%
|
-0.11
N/A
|
-0.11
N/A
|
-0.11
N/A
|
-0.11
N/A
|
-0.12
-9%
|
-0.13
-8%
|
-0.13
N/A
|
-0.12
+8%
|
-0.11
+8%
|
-0.09
+18%
|
-0.08
+11%
|
-0.07
+12%
|
-0.05
+29%
|
-0.04
+20%
|
-0.03
+25%
|
-0.03
N/A
|
-0.03
N/A
|
-0.03
N/A
|
-0.03
N/A
|
-0.04
-33%
|
-0.04
N/A
|
-0.04
N/A
|
-0.02
+50%
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|